Combined Effect of TLR2 Ligands on ROS Production by Mouse Peritoneal Macrophages


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

TLR2-mediated ROS production by mouse peritoneal macrophages was studied by luminoldependent chemiluminescence under conditions of cell stimulation with zymosan (TLR2/6 ligand) and peptidoglycan (TLR2/1 ligand). ROS production by macrophages stimulated with zymosan and peptidoglycan simultaneously depended on the ratio of ligand concentrations. Three effects were revealed: additivity of the stimulating effects of the ligands used, competitive ligand binding, and effect of macrophage priming with peptidoglycan during cell stimulation with zymosan. The mechanisms of these effects are discussed.

About the authors

Yu. O. Teselkin

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Author for correspondence.
Email: teselkin-box@mail.ru
Russian Federation, Moscow

M. V. Khoreva

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow

A. V. Veselova

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow

I. V. Babenkova

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow

A. N. Osipov

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow

L. V. Gankovskaya

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow

Yu. A. Vladimirov

N. I. Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation

Email: teselkin-box@mail.ru
Russian Federation, Moscow


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies